Tudor Moldoveanu
Concepts (231)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
bcl-2 Homologous Antagonist-Killer Protein | 9 | 2022 | 22 | 4.200 |
Why?
| Apoptosis | 21 | 2024 | 1302 | 3.820 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 13 | 2022 | 158 | 3.820 |
Why?
| Mitochondria | 8 | 2024 | 490 | 2.300 |
Why?
| Mitochondrial Membranes | 8 | 2021 | 25 | 2.020 |
Why?
| Calpain | 14 | 2010 | 28 | 1.930 |
Why?
| bcl-2-Associated X Protein | 7 | 2023 | 73 | 1.610 |
Why?
| Protein Kinases | 4 | 2019 | 88 | 1.570 |
Why?
| BH3 Interacting Domain Death Agonist Protein | 8 | 2023 | 15 | 1.430 |
Why?
| Inositol Phosphates | 2 | 2019 | 14 | 0.860 |
Why?
| Membrane Proteins | 2 | 2022 | 389 | 0.760 |
Why?
| MAP Kinase Kinase Kinases | 1 | 2019 | 18 | 0.730 |
Why?
| Protein Conformation | 11 | 2020 | 226 | 0.710 |
Why?
| Crystallography, X-Ray | 10 | 2022 | 178 | 0.680 |
Why?
| Cell Membrane Permeability | 2 | 2018 | 28 | 0.680 |
Why?
| Animals | 29 | 2024 | 14409 | 0.650 |
Why?
| Necrosis | 1 | 2018 | 208 | 0.630 |
Why?
| Binding Sites | 10 | 2020 | 440 | 0.580 |
Why?
| Calcium | 6 | 2008 | 434 | 0.530 |
Why?
| Permeability | 6 | 2019 | 87 | 0.500 |
Why?
| Protein Structure, Tertiary | 11 | 2016 | 289 | 0.490 |
Why?
| Amino Acid Sequence | 16 | 2020 | 767 | 0.480 |
Why?
| Models, Molecular | 12 | 2020 | 423 | 0.480 |
Why?
| Catalytic Domain | 3 | 2008 | 61 | 0.410 |
Why?
| Molecular Sequence Data | 13 | 2010 | 980 | 0.390 |
Why?
| Phosphorylation | 5 | 2019 | 613 | 0.390 |
Why?
| Liposomes | 3 | 2022 | 53 | 0.390 |
Why?
| Protein Multimerization | 5 | 2016 | 54 | 0.380 |
Why?
| Ligands | 3 | 2022 | 229 | 0.380 |
Why?
| Humans | 27 | 2022 | 54391 | 0.370 |
Why?
| Protein Structure, Secondary | 7 | 2018 | 99 | 0.360 |
Why?
| Protein Binding | 7 | 2020 | 736 | 0.360 |
Why?
| Enzyme Activation | 4 | 2019 | 328 | 0.350 |
Why?
| Magnetic Resonance Spectroscopy | 4 | 2018 | 255 | 0.350 |
Why?
| Signal Transduction | 8 | 2020 | 1752 | 0.340 |
Why?
| Calcium-Binding Proteins | 1 | 2008 | 61 | 0.330 |
Why?
| Glycoproteins | 2 | 2007 | 132 | 0.310 |
Why?
| Leucine | 2 | 2004 | 113 | 0.300 |
Why?
| Mice | 12 | 2024 | 6428 | 0.300 |
Why?
| Zinc Compounds | 1 | 2006 | 1 | 0.300 |
Why?
| Leupeptins | 3 | 2006 | 8 | 0.290 |
Why?
| Chlorides | 1 | 2006 | 58 | 0.290 |
Why?
| Cell Death | 3 | 2022 | 223 | 0.290 |
Why?
| Kinetics | 4 | 2020 | 692 | 0.280 |
Why?
| Protein Processing, Post-Translational | 2 | 2020 | 183 | 0.240 |
Why?
| Cytochromes c | 3 | 2020 | 41 | 0.240 |
Why?
| bcl-X Protein | 5 | 2017 | 61 | 0.230 |
Why?
| Dimerization | 3 | 2020 | 58 | 0.230 |
Why?
| Fatty Acids | 1 | 2024 | 175 | 0.220 |
Why?
| Rats | 9 | 2008 | 3419 | 0.220 |
Why?
| HT29 Cells | 2 | 2019 | 12 | 0.220 |
Why?
| Proto-Oncogene Proteins | 4 | 2017 | 169 | 0.210 |
Why?
| Calcium Signaling | 1 | 2002 | 59 | 0.210 |
Why?
| Cell Survival | 3 | 2019 | 657 | 0.200 |
Why?
| Lipids | 1 | 2022 | 178 | 0.200 |
Why?
| Sequence Alignment | 6 | 2011 | 146 | 0.190 |
Why?
| Cytochromes | 1 | 2020 | 2 | 0.190 |
Why?
| Molecular Conformation | 2 | 2019 | 73 | 0.190 |
Why?
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 868 | 0.190 |
Why?
| Cytosol | 1 | 2020 | 101 | 0.180 |
Why?
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2018 | 10 | 0.180 |
Why?
| Sf9 Cells | 1 | 2019 | 1 | 0.180 |
Why?
| Spodoptera | 1 | 2019 | 5 | 0.180 |
Why?
| Peptide Fragments | 6 | 2017 | 242 | 0.170 |
Why?
| Structural Homology, Protein | 1 | 2018 | 9 | 0.160 |
Why?
| Ion Channel Gating | 1 | 2018 | 47 | 0.160 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 42 | 0.160 |
Why?
| Protein Stability | 1 | 2018 | 44 | 0.160 |
Why?
| Cell Line | 2 | 2019 | 1152 | 0.160 |
Why?
| Mutation | 4 | 2018 | 1504 | 0.160 |
Why?
| Mutagenesis | 1 | 2018 | 77 | 0.160 |
Why?
| Carrier Proteins | 1 | 2020 | 360 | 0.160 |
Why?
| Androgen Receptor Antagonists | 1 | 2017 | 1 | 0.160 |
Why?
| Alzheimer Disease | 1 | 2022 | 369 | 0.160 |
Why?
| Glycine | 1 | 2018 | 70 | 0.160 |
Why?
| Histones | 1 | 2020 | 335 | 0.160 |
Why?
| Receptors, Androgen | 1 | 2017 | 49 | 0.150 |
Why?
| Fibroblasts | 2 | 2016 | 386 | 0.150 |
Why?
| Tumor Suppressor Proteins | 1 | 2017 | 141 | 0.140 |
Why?
| Recombinant Fusion Proteins | 2 | 2011 | 206 | 0.140 |
Why?
| Endoplasmic Reticulum-Associated Degradation | 1 | 2016 | 1 | 0.140 |
Why?
| Colonic Neoplasms | 1 | 2018 | 164 | 0.140 |
Why?
| Cysteine Proteinase Inhibitors | 2 | 2007 | 28 | 0.140 |
Why?
| Phosphatidylinositol Phosphates | 1 | 2016 | 15 | 0.140 |
Why?
| Repressor Proteins | 1 | 2017 | 165 | 0.140 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2015 | 26 | 0.140 |
Why?
| Transcription, Genetic | 1 | 2017 | 418 | 0.140 |
Why?
| Apoptosis Regulatory Proteins | 3 | 2011 | 96 | 0.130 |
Why?
| Recombinant Proteins | 3 | 2006 | 570 | 0.130 |
Why?
| Models, Biological | 2 | 2015 | 825 | 0.120 |
Why?
| Coenzyme A | 1 | 2013 | 9 | 0.120 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2013 | 19 | 0.120 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2015 | 251 | 0.120 |
Why?
| Xenopus laevis | 1 | 2013 | 49 | 0.120 |
Why?
| Hydrolysis | 2 | 2003 | 68 | 0.120 |
Why?
| Mutant Proteins | 1 | 2013 | 41 | 0.110 |
Why?
| Oocytes | 1 | 2013 | 94 | 0.110 |
Why?
| Mice, Inbred C57BL | 1 | 2018 | 2001 | 0.110 |
Why?
| Mitochondria, Liver | 1 | 2011 | 86 | 0.100 |
Why?
| Substrate Specificity | 2 | 2008 | 209 | 0.100 |
Why?
| Receptors, Interleukin-4 | 1 | 2010 | 3 | 0.100 |
Why?
| Sequence Homology, Amino Acid | 3 | 2010 | 180 | 0.100 |
Why?
| Alternative Splicing | 2 | 2017 | 64 | 0.100 |
Why?
| Interleukin-4 | 1 | 2010 | 48 | 0.090 |
Why?
| Selection, Genetic | 1 | 2010 | 27 | 0.090 |
Why?
| Evolution, Molecular | 1 | 2010 | 103 | 0.090 |
Why?
| Structure-Activity Relationship | 2 | 2008 | 423 | 0.090 |
Why?
| EF Hand Motifs | 1 | 2008 | 1 | 0.090 |
Why?
| Protease Inhibitors | 2 | 2006 | 64 | 0.080 |
Why?
| Biocatalysis | 1 | 2008 | 20 | 0.080 |
Why?
| Mice, Knockout | 3 | 2017 | 927 | 0.080 |
Why?
| Cathepsins | 2 | 2007 | 8 | 0.080 |
Why?
| Mutagenesis, Site-Directed | 3 | 2003 | 117 | 0.080 |
Why?
| Proto-Oncogene Proteins c-cbl | 1 | 2007 | 3 | 0.080 |
Why?
| Phenotype | 2 | 2017 | 819 | 0.080 |
Why?
| Ubiquitin | 1 | 2007 | 51 | 0.080 |
Why?
| Combinatorial Chemistry Techniques | 1 | 2007 | 9 | 0.080 |
Why?
| KB Cells | 1 | 2006 | 5 | 0.070 |
Why?
| Neoplasms | 1 | 2017 | 1322 | 0.070 |
Why?
| Epoxy Compounds | 1 | 2007 | 48 | 0.070 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 124 | 0.070 |
Why?
| Micelles | 1 | 2006 | 12 | 0.070 |
Why?
| Gene Expression Regulation | 1 | 2011 | 1063 | 0.070 |
Why?
| Peptide Library | 1 | 2005 | 29 | 0.070 |
Why?
| Phospholipids | 1 | 2006 | 63 | 0.070 |
Why?
| Isoenzymes | 2 | 2006 | 177 | 0.060 |
Why?
| Papain | 1 | 2004 | 5 | 0.060 |
Why?
| Cathepsin K | 1 | 2004 | 7 | 0.060 |
Why?
| Magnesium | 2 | 2004 | 42 | 0.060 |
Why?
| Crystallization | 1 | 2004 | 46 | 0.060 |
Why?
| Protein Isoforms | 2 | 2002 | 124 | 0.060 |
Why?
| Coenzyme A Ligases | 1 | 2024 | 5 | 0.060 |
Why?
| Transposases | 1 | 2004 | 10 | 0.060 |
Why?
| Protein Precursors | 1 | 2004 | 47 | 0.060 |
Why?
| Sensitivity and Specificity | 1 | 2006 | 922 | 0.060 |
Why?
| Peptides | 1 | 2005 | 276 | 0.060 |
Why?
| Calorimetry, Differential Scanning | 1 | 2003 | 6 | 0.060 |
Why?
| Transfection | 2 | 2017 | 399 | 0.060 |
Why?
| Calcium Chloride | 1 | 2003 | 2 | 0.060 |
Why?
| HEK293 Cells | 2 | 2017 | 245 | 0.060 |
Why?
| Protein Folding | 1 | 2003 | 52 | 0.060 |
Why?
| Restriction Mapping | 1 | 2003 | 32 | 0.060 |
Why?
| Tryptophan | 1 | 2003 | 102 | 0.060 |
Why?
| Cell Proliferation | 2 | 2017 | 1097 | 0.060 |
Why?
| Molecular Mimicry | 2 | 2017 | 64 | 0.060 |
Why?
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2022 | 1 | 0.060 |
Why?
| Temperature | 1 | 2003 | 177 | 0.060 |
Why?
| Proteins | 1 | 2006 | 376 | 0.050 |
Why?
| Oxidation-Reduction | 1 | 2024 | 383 | 0.050 |
Why?
| RNA Splicing | 1 | 2022 | 38 | 0.050 |
Why?
| Endoplasmic Reticulum | 2 | 2016 | 123 | 0.050 |
Why?
| Dose-Response Relationship, Drug | 2 | 2003 | 1476 | 0.050 |
Why?
| Cell Membrane | 2 | 2016 | 279 | 0.050 |
Why?
| Molecular Structure | 2 | 2017 | 319 | 0.050 |
Why?
| Muscular Dystrophies | 1 | 2001 | 16 | 0.050 |
Why?
| Chymotrypsin | 1 | 2001 | 3 | 0.050 |
Why?
| Trypsin | 1 | 2001 | 17 | 0.050 |
Why?
| Molecular Weight | 1 | 2001 | 100 | 0.050 |
Why?
| Mammals | 2 | 2011 | 59 | 0.050 |
Why?
| Catalysis | 1 | 2001 | 98 | 0.050 |
Why?
| Sequence Homology | 1 | 2020 | 21 | 0.050 |
Why?
| Proteome | 1 | 2022 | 178 | 0.050 |
Why?
| Amino Acid Motifs | 1 | 2020 | 57 | 0.050 |
Why?
| Molecular Dynamics Simulation | 1 | 2020 | 40 | 0.050 |
Why?
| Jurkat Cells | 1 | 2018 | 34 | 0.040 |
Why?
| Muscle Proteins | 1 | 2001 | 307 | 0.040 |
Why?
| Herpesvirus 1, Human | 1 | 2018 | 15 | 0.040 |
Why?
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2018 | 25 | 0.040 |
Why?
| Anilides | 1 | 2017 | 18 | 0.040 |
Why?
| NIH 3T3 Cells | 1 | 2017 | 55 | 0.040 |
Why?
| Mice, Inbred NOD | 1 | 2017 | 99 | 0.040 |
Why?
| Mice, SCID | 1 | 2017 | 196 | 0.040 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2017 | 219 | 0.040 |
Why?
| RNA Interference | 1 | 2017 | 195 | 0.040 |
Why?
| Mice, Nude | 1 | 2017 | 284 | 0.040 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 206 | 0.040 |
Why?
| Embryo, Mammalian | 1 | 2016 | 69 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2018 | 435 | 0.030 |
Why?
| Genotype | 1 | 2017 | 600 | 0.030 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2016 | 131 | 0.030 |
Why?
| Indoles | 1 | 2017 | 289 | 0.030 |
Why?
| Caspase 2 | 1 | 2013 | 4 | 0.030 |
Why?
| Transcriptional Activation | 1 | 2013 | 134 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2017 | 1551 | 0.030 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2013 | 151 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2017 | 1141 | 0.030 |
Why?
| Molecular Sequence Annotation | 1 | 2011 | 31 | 0.030 |
Why?
| Protein Structure, Quaternary | 1 | 2010 | 28 | 0.020 |
Why?
| HeLa Cells | 1 | 2011 | 291 | 0.020 |
Why?
| Likelihood Functions | 1 | 2010 | 61 | 0.020 |
Why?
| Calorimetry | 1 | 2010 | 9 | 0.020 |
Why?
| Time Factors | 1 | 2017 | 3210 | 0.020 |
Why?
| Multigene Family | 1 | 2010 | 54 | 0.020 |
Why?
| Species Specificity | 1 | 2010 | 206 | 0.020 |
Why?
| Protein Interaction Mapping | 1 | 2010 | 44 | 0.020 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 208 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2010 | 370 | 0.020 |
Why?
| Phylogeny | 1 | 2010 | 269 | 0.020 |
Why?
| Sequence Analysis, DNA | 1 | 2010 | 274 | 0.020 |
Why?
| Genetic Variation | 1 | 2010 | 253 | 0.020 |
Why?
| Antineoplastic Agents | 1 | 2017 | 1300 | 0.020 |
Why?
| Autophagy | 1 | 2010 | 202 | 0.020 |
Why?
| Receptor Protein-Tyrosine Kinases | 1 | 2007 | 52 | 0.020 |
Why?
| Solutions | 1 | 2006 | 29 | 0.020 |
Why?
| Hydrogen Bonding | 1 | 2006 | 45 | 0.020 |
Why?
| Conserved Sequence | 1 | 2006 | 57 | 0.020 |
Why?
| Electron Spin Resonance Spectroscopy | 1 | 2006 | 12 | 0.020 |
Why?
| Cysteine | 1 | 2006 | 62 | 0.020 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 34 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2006 | 194 | 0.020 |
Why?
| Consensus Sequence | 1 | 2005 | 25 | 0.020 |
Why?
| Biotinylation | 1 | 2005 | 23 | 0.020 |
Why?
| Chromatography, Gel | 1 | 2005 | 47 | 0.020 |
Why?
| Fluorescence Resonance Energy Transfer | 1 | 2005 | 17 | 0.020 |
Why?
| Water | 1 | 2006 | 103 | 0.020 |
Why?
| Acetylation | 1 | 2005 | 99 | 0.020 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 79 | 0.020 |
Why?
| Computer Simulation | 1 | 2006 | 332 | 0.020 |
Why?
| Nitrilotriacetic Acid | 1 | 2004 | 2 | 0.020 |
Why?
| Edetic Acid | 1 | 2004 | 15 | 0.020 |
Why?
| Nickel | 1 | 2004 | 13 | 0.020 |
Why?
| Chelating Agents | 1 | 2004 | 28 | 0.020 |
Why?
| Sequence Deletion | 1 | 2004 | 99 | 0.010 |
Why?
| Salts | 1 | 2000 | 8 | 0.010 |
Why?
| Serine | 1 | 2000 | 44 | 0.010 |
Why?
| Cysteine Endopeptidases | 1 | 2000 | 75 | 0.010 |
Why?
| Point Mutation | 1 | 2000 | 92 | 0.010 |
Why?
| Lysine | 1 | 2000 | 102 | 0.010 |
Why?
| Glutamic Acid | 1 | 2000 | 111 | 0.010 |
Why?
| Male | 1 | 2017 | 27347 | 0.010 |
Why?
| Female | 1 | 2017 | 28471 | 0.010 |
Why?
|
|
Moldoveanu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|